Risk factor
Very poor trading liquidity
Profitability factor
Very low or no dividends
About
MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and commercialization of diabetes management medical devices and consumables in the People's Republic of China and internationally. Its products include Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems, blood glucose monitoring systems, and closed-loop artificial pancreas. The company...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, reasonably priced on P/F
Target Price
The average target price of 2235.HK is 7.1 and suggests 5% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to de
Buy
Sell